Advertisement
Screener

Q/C Technologies, Inc. (QCLS) Proceeds from Sale and Maturity of Marketable Securities

Q/C Technologies, Inc. Proceeds from Sale and Maturity of Marketable Securities

Q/C Technologies, Inc. (QCLS) reported Proceeds from Sale and Maturity of Marketable Securities of $4.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-12

  • Q/C Technologies, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $1.26M, a 44.18% decline year-over-year.
  • Q/C Technologies, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $3.12M, a 62.88% decline year-over-year.
  • Q/C Technologies, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $1.44M, a 15.05% increase year-over-year.
  • Q/C Technologies, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $550.00K, a 83.08% decline year-over-year.
  • Q/C Technologies, Inc. proceeds from sale and maturity of marketable securities for fiscal 2025 was $12.65M, a 87.36% increase from fiscal 2024.
  • Q/C Technologies, Inc. proceeds from sale and maturity of marketable securities for fiscal 2024 was $6.75M, a 55.88% decline from fiscal 2023.
  • Q/C Technologies, Inc. proceeds from sale and maturity of marketable securities for fiscal 2023 was $15.30M, a 30.21% increase from fiscal 2022.
  • Q/C Technologies, Inc. proceeds from sale and maturity of marketable securities for fiscal 2022 was $11.75M, a 36.43% decline from fiscal 2021.
Period endProceeds from Sale and Maturity of Marketable Securities 3 monthProceeds from Sale and Maturity of Marketable Securities 3 month as first filedProceeds from Sale and Maturity of Marketable Securities 6 monthProceeds from Sale and Maturity of Marketable Securities 6 month as first filedProceeds from Sale and Maturity of Marketable Securities 9 monthProceeds from Sale and Maturity of Marketable Securities 12 month
2026-06-30$1.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$4.38M
10-Q · filed 2026-08-12
$5.82M
derived: sum of 3 quarters · filed 2026-08-12
$6.37M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$3.12M
10-Q · filed 2026-05-15
$4.56M
derived: sum of 2 quarters · filed 2026-05-15
$5.11M
derived: sum of 3 quarters · filed 2026-05-15
$7.37M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$1.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$1.99M
derived: sum of 2 quarters · filed 2026-04-15
$4.25M
derived: sum of 3 quarters · filed 2026-08-12
$12.65M
10-K · filed 2026-04-15
2025-09-30$550.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19
$2.81M
derived: sum of 2 quarters · filed 2026-08-12
$11.21M
10-Q · filed 2025-11-19
$12.46M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$2.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$10.66M
10-Q · filed 2026-08-12
$11.91M
derived: sum of 3 quarters · filed 2026-08-12
$15.16M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$8.40M
10-Q · filed 2026-05-15
$9.65M
derived: sum of 2 quarters · filed 2026-05-15
$12.90M
derived: sum of 3 quarters · filed 2026-05-15
$14.40M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$1.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$4.50M
derived: sum of 2 quarters · filed 2026-04-15
$6.00M
derived: sum of 3 quarters · filed 2026-04-15
$6.75M
10-K · filed 2026-04-15
2024-09-30$3.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19
$4.75M
derived: sum of 2 quarters · filed 2025-11-19
$5.50M
10-Q · filed 2025-11-19
$11.55M
derived: sum of 4 quarters · filed 2025-11-19
2024-06-30$1.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19
$2.25M
10-Q · filed 2025-08-19
$8.30M
derived: sum of 3 quarters · filed 2025-08-19
$11.80M
derived: sum of 4 quarters · filed 2025-08-19
2024-03-31$750.33K
10-Q · filed 2025-05-15
$6.80M
derived: sum of 2 quarters · filed 2025-05-15
$10.30M
derived: sum of 3 quarters · filed 2025-05-15
$14.30M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$6.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11
$9.55M
derived: sum of 2 quarters · filed 2025-04-11
$13.55M
derived: sum of 3 quarters · filed 2025-04-11
$15.30M
10-K · filed 2025-04-11
2023-09-30$3.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$7.50M
derived: sum of 2 quarters · filed 2024-11-14
$9.25M
10-Q · filed 2024-11-14
$12.00M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19
$5.75M
10-Q · filed 2024-08-19
$8.50M
derived: sum of 3 quarters · filed 2024-08-19
$11.00M
derived: sum of 4 quarters · filed 2024-08-19
2023-03-31$1.75M
10-Q · filed 2024-05-15
$4.50M
derived: sum of 2 quarters · filed 2024-05-15
$7.00M
derived: sum of 3 quarters · filed 2024-05-15
$10.50M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$2.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$5.25M
derived: sum of 2 quarters · filed 2024-04-01
$8.75M
derived: sum of 3 quarters · filed 2024-04-01
$11.75M
10-K · filed 2024-04-01
2022-09-30$2.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$6.00M
derived: sum of 2 quarters · filed 2023-11-14
$9.00M
10-Q · filed 2023-11-14
$12.00M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$3.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$6.50M
10-Q · filed 2023-08-14
$9.50M
derived: sum of 3 quarters · filed 2023-08-14
$15.00M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$3.00M
10-Q · filed 2023-05-15
$6.00M
derived: sum of 2 quarters · filed 2023-05-15
$11.50M
derived: sum of 3 quarters · filed 2023-05-15
$21.48M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$8.50M
derived: sum of 2 quarters · filed 2023-03-31
$18.48M
derived: sum of 3 quarters · filed 2023-03-31
$18.48M
10-K · filed 2023-03-31
2021-09-30$5.50M
10-Q/A · filed 2021-11-15
$15.48M
derived: sum of 2 quarters · filed 2021-11-15
$15.48M
10-Q · filed 2022-11-10
$15.49M
derived: sum of 4 quarters · filed 2022-05-16
2021-06-30$9.98M
10-Q · filed 2021-08-16
$9.98M
10-Q · filed 2022-08-15
$9.99M
derived: sum of 3 quarters · filed 2022-05-16
$9.99M
derived: sum of 4 quarters · filed 2022-05-16
2021-03-31$0.00
10-Q · filed 2022-05-16
$3.48K
derived: sum of 2 quarters · filed 2022-05-16
$6.91K
derived: sum of 3 quarters · filed 2022-05-16
$6.91K
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$3.48K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$6.91K
derived: sum of 2 quarters · filed 2021-03-01
$6.91K
derived: sum of 3 quarters · filed 2021-08-16
$2.31M
10-K · filed 2021-03-01
2020-09-30$3.44K
10-Q · filed 2020-11-16
$3.44K
derived: sum of 2 quarters · filed 2021-08-16
$2.31M
10-Q · filed 2020-11-16
$2.61M
derived: sum of 4 quarters · filed 2021-08-16
2020-06-30$0.00
10-Q · filed 2021-08-16
$3.57K
10-Q · filed 2020-08-14
$0.00
10-Q · filed 2021-08-16
$502.13K
10-Q · filed 2020-08-14
$2.61M
derived: sum of 3 quarters · filed 2021-08-16
$3.81M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$2.30M
10-Q · filed 2020-05-15
$2.61M
derived: sum of 2 quarters · filed 2021-03-01
$3.81M
derived: sum of 3 quarters · filed 2021-03-01
$6.11M
derived: sum of 4 quarters · filed 2021-03-01
2019-12-31$301.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$1.50M
derived: sum of 2 quarters · filed 2021-03-01
$3.81M
derived: sum of 3 quarters · filed 2021-03-01
$2.86M
10-K · filed 2021-03-01
2019-09-30$1.20M
10-Q · filed 2020-11-16
$3.51M
derived: sum of 2 quarters · filed 2020-11-16
$2.56M
10-Q · filed 2020-11-16
$5.21M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$2.31M
10-Q · filed 2020-08-14
$502.13K
10-Q · filed 2019-08-14
$1.35M
10-Q · filed 2020-08-14
$4.01M
derived: sum of 3 quarters · filed 2020-08-14
$7.17M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$852.52K
10-Q · filed 2020-05-15
$1.71M
derived: sum of 2 quarters · filed 2020-05-15
$4.86M
derived: sum of 3 quarters · filed 2020-05-15
$6.86M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$852.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25
$4.01M
derived: sum of 2 quarters · filed 2020-03-25
$6.01M
derived: sum of 3 quarters · filed 2020-03-25
$6.31M
10-K · filed 2020-03-25
2018-09-30$3.15M
10-Q · filed 2019-11-14
$5.16M
derived: sum of 2 quarters · filed 2019-11-14
$5.46M
10-Q · filed 2019-11-14
$5.46M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$2.00M
10-Q · filed 2019-08-14
$2.31M
10-Q · filed 2019-08-14
$2.31M
derived: sum of 3 quarters · filed 2019-08-14
$3.31M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$302.10K
10-Q · filed 2018-07-13
$302.12K
derived: sum of 2 quarters · filed 2018-07-13
$1.31M
derived: sum of 3 quarters · filed 2018-11-14
$1.96M
derived: sum of 4 quarters · filed 2018-11-14
2017-12-31$28.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-07-13
$1.00M
derived: sum of 2 quarters · filed 2018-11-14
$1.65M
derived: sum of 3 quarters · filed 2018-11-14
$2.75M
10-K/A · filed 2018-07-13
2017-09-30$1.00M
10-Q · filed 2018-11-14
$1.65M
derived: sum of 2 quarters · filed 2018-11-14
$2.75M
10-Q · filed 2018-11-14
$3.30M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$650.34K
10-Q · filed 2018-08-14
$650.66K
10-Q · filed 2017-08-14
$1.75M
10-Q · filed 2018-08-14
$2.30M
derived: sum of 3 quarters · filed 2018-08-14
$3.25M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$1.10M
10-Q · filed 2018-07-13
$1.65M
derived: sum of 2 quarters · filed 2018-07-13
$2.60M
derived: sum of 3 quarters · filed 2018-07-13
$3.50M
derived: sum of 4 quarters · filed 2018-07-13
2016-12-31$550.20K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13
$1.50M
derived: sum of 2 quarters · filed 2018-07-13
$2.40M
derived: sum of 3 quarters · filed 2018-07-13
$4.00M
10-K/A · filed 2018-07-13
2016-09-30$950.51K
10-Q/A · filed 2018-07-13
$1.85M
derived: sum of 2 quarters · filed 2018-07-13
$3.45M
10-Q/A · filed 2018-07-13
$4.65M
derived: sum of 4 quarters · filed 2018-07-13
2016-06-30$900.86K
10-Q/A · filed 2018-07-13
$2.50M
10-Q/A · filed 2018-07-13
$3.70M
derived: sum of 3 quarters · filed 2018-07-13
$4.91M
derived: sum of 4 quarters · filed 2018-07-13
2016-03-31$1.60M
10-Q · filed 2017-05-15
$2.80M
derived: sum of 2 quarters · filed 2017-05-15
$4.01M
derived: sum of 3 quarters · filed 2017-05-15
$5.66M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11
$2.40M
derived: sum of 2 quarters · filed 2017-04-11
$4.06M
derived: sum of 3 quarters · filed 2017-04-11
$5.31M
10-K · filed 2017-04-11
2015-09-30$1.20M
10-Q · filed 2016-11-14
$2.86M
derived: sum of 2 quarters · filed 2016-11-14
$4.11M
10-Q · filed 2016-11-14
$5.06M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$1.65M
10-Q · filed 2016-08-11
$1.65M
10-Q · filed 2015-08-18
$2.91M
10-Q · filed 2016-08-11
$3.86M
derived: sum of 3 quarters · filed 2016-08-11
$5.11M
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31$1.25M
10-Q · filed 2016-05-12
$2.21M
derived: sum of 2 quarters · filed 2016-05-12
$3.46M
derived: sum of 3 quarters · filed 2016-05-12
$4.54M
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31$953.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$2.20M
derived: sum of 2 quarters · filed 2016-03-30
$3.28M
derived: sum of 3 quarters · filed 2016-03-30
$3.28M
10-K · filed 2016-03-30
2014-09-30$1.25M
10-Q · filed 2015-11-13
$2.33M
derived: sum of 2 quarters · filed 2015-11-13
$2.33M
10-Q · filed 2015-11-13
2014-06-30$1.08M
10-Q · filed 2015-08-18
$1.08M
10-Q · filed 2015-08-18
2014-03-31$1.71K
10-Q · filed 2015-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92